Innov Clin Neurosci. 2026;23(4–6):51–55. by Takahiko Nagamine, MD, PhD Dr. Nagamine is with the Department of Psychiatric Internal Medicine, Sunlight Brain Research Center, Hofu, Japan and the Graduate School of
Innov Clin Neurosci. 2026;23(4–6):56–61. by Alexandra R. Rola, PharmD; Jared R. Bagley, PhD; and Emily E. Leppien, PharmD, BCPS, BCPP All authors are with the Binghamton University School of Pharmacy
Innov Clin Neurosci. 2026;23(4–6):62–63. by Charles D. Cash, JD, LLM Mr. Cash is Associate Director of Risk Management at Professional Risk Management Services (PRMS). FUNDING: No funding was provided for
Research Summary: Depressive symptoms are common in older adults and have been associated with risk of Alzheimer’s disease and Alzheimer’s disease and related dementias (AD/ADRD), but the mechanisms and biomarkers
Rising mortality related to early-onset Alzheimer’s disease in the United States: trends and disparities, 2003–2023. This retrospective population-based study used Centers for Disease Control (CDC) and Prevention WONDER data to
Neuroplasticity and Alzheimer’s disease Gashtrodkhani AA, Shirkouhi SG, Khatami SS, et al. J Integr Neurosci. 2026;25(1):48051. Summary. In a narrative review of literature investigating neuroplasticity related to Alzheimer’s disease, researchers
